121 related articles for article (PubMed ID: 17675228)
1. Peripheral blood and bone marrow TNF and TNF receptors in early and advanced stages of B-CLL in correlation with ZAP-70 protein and CD38 antigen.
Bojarska-Junak A; Hus I; Szczepanek EW; Dmoszyńska A; Roliński J
Leuk Res; 2008 Feb; 32(2):225-33. PubMed ID: 17675228
[TBL] [Abstract][Full Text] [Related]
2. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
[TBL] [Abstract][Full Text] [Related]
3. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia.
Ertault-Daneshpouy M; Noguera ME; Gisselbrecht C; Haddad A; Brice P; Marolleau JP; Soulier J; Mounier N
Clin Adv Hematol Oncol; 2008 Jan; 6(1):55-63. PubMed ID: 18322442
[TBL] [Abstract][Full Text] [Related]
4. Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia.
Del Giudice I; Morilla A; Osuji N; Matutes E; Morilla R; Burford A; Maravelaki S; Owusu-Ankomah K; Swansbury J; A'Hern R; Brito-Babapulle V; Catovsky D
Cancer; 2005 Nov; 104(10):2124-32. PubMed ID: 16211545
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia.
D'Arena G; Tarnani M; Rumi C; Vaisitti T; Aydin S; De Filippi R; Perrone F; Pinto A; Chiusolo P; Deaglio S; Malavasi F; Laurenti L
Am J Hematol; 2007 Sep; 82(9):787-91. PubMed ID: 17534928
[TBL] [Abstract][Full Text] [Related]
6. Prognostic importance of soluble CD23 in B-cell chronic lymphocytic leukemia.
Saka B; Aktan M; Sami U; Oner D; Sanem O; Dinçol G
Clin Lab Haematol; 2006 Feb; 28(1):30-5. PubMed ID: 16430457
[TBL] [Abstract][Full Text] [Related]
7. Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels.
Rivkina A; Vitols G; Murovska M; Lejniece S
Exp Oncol; 2011 Jun; 33(2):99-103. PubMed ID: 21716207
[TBL] [Abstract][Full Text] [Related]
8. Comparison of bone marrow and peripheral blood ZAP-70 status examined by flow cytometric immunophenotyping in patients with chronic lymphocytic leukemia.
Sheridan R; Mounajjed T; Ehrmann DE; Hurtubise PE; Schrager JA
Cytometry B Clin Cytom; 2006 Jul; 70(4):320-1. PubMed ID: 16906578
[TBL] [Abstract][Full Text] [Related]
9. T-cell CD38 expression in B-chronic lymphocytic leukaemia.
Abousamra NK; El-Din MS; Azmy E
Hematol Oncol; 2009 Jun; 27(2):82-9. PubMed ID: 19247976
[TBL] [Abstract][Full Text] [Related]
10. Discordance of ZAP-70 in patients with chronic lymphocytic leukemia.
Chaar BT; Schergen AK; Grosso LE
Int J Lab Hematol; 2008 Feb; 30(1):36-40. PubMed ID: 18190465
[TBL] [Abstract][Full Text] [Related]
11. Zap-70 and CD38 as predictors of IgVH mutation in CLL.
Cruse JM; Lewis RE; Webb RN; Sanders CM; Suggs JL
Exp Mol Pathol; 2007 Dec; 83(3):459-61. PubMed ID: 17931624
[TBL] [Abstract][Full Text] [Related]
12. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
Kusenda J; Babusíková O
Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of an easily applicable method of ZAP-70 measurement in chronic lymphocytic leukemia in the routine flow cytometry setting: A methodological approach.
Passam F; Tachynopoulou V; Skoumi D; Tsompanakou A; Stavropoulos-Giokas A; Vadikolia C; Anagnostopoulos A; Paterakis G
Ann Hematol; 2006 Nov; 85(11):795-805. PubMed ID: 16871389
[TBL] [Abstract][Full Text] [Related]
14. Regulation of CD38 in proliferating chronic lymphocytic leukemia cells stimulated with CD154 and interleukin-4.
Willimott S; Baou M; Huf S; Deaglio S; Wagner SD
Haematologica; 2007 Oct; 92(10):1359-66. PubMed ID: 18024373
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia.
Lai R; O'Brien S; Maushouri T; Rogers A; Kantarjian H; Keating M; Albitar M
Cancer; 2002 Sep; 95(5):1071-5. PubMed ID: 12209693
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
17. Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemia.
Giannopoulos K; Schmitt M; Kowal M; Wlasiuk P; Bojarska-Junak A; Chen J; Rolinski J; Dmoszynska A
Oncol Rep; 2008 Sep; 20(3):677-82. PubMed ID: 18695923
[TBL] [Abstract][Full Text] [Related]
18. The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Soma LA; Craig FE; Swerdlow SH
Hum Pathol; 2006 Feb; 37(2):152-9. PubMed ID: 16426914
[TBL] [Abstract][Full Text] [Related]
19. ZAP-70 and CD38 expression are independent prognostic factors in patients with B-cell chronic lymphocytic leukaemia and combined analysis improves their predictive value.
Hus I; Bojarska-Junak A; Dmoszyńska A; Wasik-Szczepanek E; Sieklucka M; Trześniewska W; Glazer M; Roliński J
Folia Histochem Cytobiol; 2008; 46(2):147-52. PubMed ID: 18519230
[TBL] [Abstract][Full Text] [Related]
20. Markers of increased angiogenesis and their correlation with biological parameters identifying high-risk patients in early B-cell chronic lymphocytic leukemia.
Molica S; Cutrona G; Vitelli G; Mirabelli R; Molica M; Digiesi G; Ribatti D; Ferrarini M; Vacca A
Leuk Res; 2007 Nov; 31(11):1575-8. PubMed ID: 17485110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
